Clinical Trial Update: An Upcoming Clinical Study to Measure the Safety and Impact of a Drug Called Macitentan in Teenage and Adult Fontan Patients. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating safety and impact of macitentan in teenage and adult Fontan patients was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Fontan Circulation

Drugs mentioned

• Macitentan (macitentan)

Snippet

Sponsor: Actelion | Conditions: Congenital Heart Disease With Fontan Circulation | Phase 3 | Status: TERMINATED | Results posted: 2023-03-07